{"transactions":[{"id":1789698,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-05T21:34:33.000Z","date":"2023-09-01","kind":"sale","planned":true,"acquired":false,"shares":68014,"price":0.1403,"value":9542.3642,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of shares of Common Stock pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of shares of restricted stock previously granted to the Reporting Person. This sale was effected pursuant to a plan adopted on November 17, 2022 in accordance with Rule 10b5-1 and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.14 to $0.1424, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":798236,"source":{"system":"sec-edgar","filing":"0000950170-23-046504","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017023046504/ownership.xml","form_type":"4"}},{"id":1947912,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-18T00:30:15.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":1800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from January 1, 2023, with the first vesting occuring on April 1, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":1800000,"derivative":{"exercise_price":0.5,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":1800000},"source":{"system":"sec-edgar","filing":"0000899243-23-009000","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323009000/doc4.xml","form_type":"4"}},{"id":2169195,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-01T20:30:33.000Z","date":"2022-08-30","kind":"tax_withholding","acquired":false,"shares":18750,"price":2.41,"value":45187.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligations in connection with the vesting of shares of restricted stock previously granted to the Reporting Person."}],"balance_after":866250,"source":{"system":"sec-edgar","filing":"0000899243-22-030186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322030186/doc4.xml","form_type":"4"}},{"id":2311585,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-01T20:30:50.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three months after January 1, 2022, subject to the Reporting Person's continued service through each such date."}],"balance_after":2000000,"derivative":{"exercise_price":0.66,"expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0000899243-22-013119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322013119/doc4.xml","form_type":"4"}},{"id":2508223,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-17T21:53:45.000Z","date":"2021-11-17","kind":"purchase","acquired":true,"shares":9116,"price":1.4,"value":12762.4,"ownership":{"direct":true},"balance_after":885000,"source":{"system":"sec-edgar","filing":"0001209191-21-065138","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121065138/doc4.xml","form_type":"4"}},{"id":2508222,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-17T21:53:45.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":884,"price":1.4,"value":1237.6,"ownership":{"direct":true},"balance_after":875884,"source":{"system":"sec-edgar","filing":"0001209191-21-065138","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121065138/doc4.xml","form_type":"4"}},{"id":2585444,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-31T20:42:26.000Z","date":"2021-08-30","kind":"grant","acquired":true,"shares":2625000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three month after 8/30/2021, subject to the Reporting Person's continued service through each such date."}],"balance_after":2625000,"derivative":{"exercise_price":1.64,"expiration_date":"2031-08-29","underlying":"Common Stock","underlying_shares":2625000},"source":{"system":"sec-edgar","filing":"0001209191-21-054089","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121054089/doc4.xml","form_type":"4"}},{"id":2585443,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-31T20:42:26.000Z","date":"2021-08-30","kind":"grant","acquired":true,"shares":875000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-fourth of the shares vest on each of August 30, 2022, August 30, 2023, August 30, 2024 and August 30, 2025, subject to the Reporting Person's continued service through each such date."}],"balance_after":875000,"source":{"system":"sec-edgar","filing":"0001209191-21-054089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121054089/doc4.xml","form_type":"4"}}]}